Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells

Several technologies have been developed to isolate human antibodies against different target antigens as a source of potential therapeutics, including hybridoma technology, phage and yeast display systems. For conventional antibodies this involves either random pairing of VH and VL domains in combi...

Full description

Bibliographic Details
Main Authors: Dubravka Drabek, Rick Janssens, Ernie de Boer, Rik Rademaker, Johannes Kloess, John Skehel, Frank Grosveld
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00619/full
id doaj-a19343b1c027431b96c8763bee94f67b
record_format Article
spelling doaj-a19343b1c027431b96c8763bee94f67b2020-11-24T23:51:07ZengFrontiers Media S.A.Frontiers in Immunology1664-32242016-12-01710.3389/fimmu.2016.00619232393Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cellsDubravka Drabek0Rick Janssens1Ernie de Boer2Rik Rademaker3Johannes Kloess4John Skehel5Frank Grosveld6Frank Grosveld7Erasmus MCErasmus MCErasmus MCHarbour Antibodies BVFrances Krick InstituteFrances Krick InstituteErasmus MCHarbour Antibodies BVSeveral technologies have been developed to isolate human antibodies against different target antigens as a source of potential therapeutics, including hybridoma technology, phage and yeast display systems. For conventional antibodies this involves either random pairing of VH and VL domains in combinatorial display libraries, or isolation of cognate pairs of VH and VL domains from human B cells or from transgenic mice carrying human immunoglobulin loci followed by single cell sorting, single cell RT-PCR and bulk cloning of isolated natural VH-VL pairs. Heavy chain only antibodies (HCAbs) that naturally occur in camelids require only heavy immunoglobulin chain cloning. Here, we present an automatable novel, high-throughput technology, for rapid direct cloning and production of fully human HCAbs from sorted population of transgenic mouse plasma cells carrying a human HCAb locus. Utility of the technique is demonstrated by isolation of diverse sets of sequence unique, soluble, high affinity influenza A strain X-31 hemagglutinin (HA) specific HCAbshttp://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00619/fullPlasma CellsTransgenic micehuman VhHCAbHEK cell library
collection DOAJ
language English
format Article
sources DOAJ
author Dubravka Drabek
Rick Janssens
Ernie de Boer
Rik Rademaker
Johannes Kloess
John Skehel
Frank Grosveld
Frank Grosveld
spellingShingle Dubravka Drabek
Rick Janssens
Ernie de Boer
Rik Rademaker
Johannes Kloess
John Skehel
Frank Grosveld
Frank Grosveld
Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells
Frontiers in Immunology
Plasma Cells
Transgenic mice
human Vh
HCAb
HEK cell library
author_facet Dubravka Drabek
Rick Janssens
Ernie de Boer
Rik Rademaker
Johannes Kloess
John Skehel
Frank Grosveld
Frank Grosveld
author_sort Dubravka Drabek
title Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells
title_short Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells
title_full Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells
title_fullStr Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells
title_full_unstemmed Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells
title_sort expression cloning and production of human heavy chain only antibodies from murine transgenic plasma cells
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2016-12-01
description Several technologies have been developed to isolate human antibodies against different target antigens as a source of potential therapeutics, including hybridoma technology, phage and yeast display systems. For conventional antibodies this involves either random pairing of VH and VL domains in combinatorial display libraries, or isolation of cognate pairs of VH and VL domains from human B cells or from transgenic mice carrying human immunoglobulin loci followed by single cell sorting, single cell RT-PCR and bulk cloning of isolated natural VH-VL pairs. Heavy chain only antibodies (HCAbs) that naturally occur in camelids require only heavy immunoglobulin chain cloning. Here, we present an automatable novel, high-throughput technology, for rapid direct cloning and production of fully human HCAbs from sorted population of transgenic mouse plasma cells carrying a human HCAb locus. Utility of the technique is demonstrated by isolation of diverse sets of sequence unique, soluble, high affinity influenza A strain X-31 hemagglutinin (HA) specific HCAbs
topic Plasma Cells
Transgenic mice
human Vh
HCAb
HEK cell library
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00619/full
work_keys_str_mv AT dubravkadrabek expressioncloningandproductionofhumanheavychainonlyantibodiesfrommurinetransgenicplasmacells
AT rickjanssens expressioncloningandproductionofhumanheavychainonlyantibodiesfrommurinetransgenicplasmacells
AT erniedeboer expressioncloningandproductionofhumanheavychainonlyantibodiesfrommurinetransgenicplasmacells
AT rikrademaker expressioncloningandproductionofhumanheavychainonlyantibodiesfrommurinetransgenicplasmacells
AT johanneskloess expressioncloningandproductionofhumanheavychainonlyantibodiesfrommurinetransgenicplasmacells
AT johnskehel expressioncloningandproductionofhumanheavychainonlyantibodiesfrommurinetransgenicplasmacells
AT frankgrosveld expressioncloningandproductionofhumanheavychainonlyantibodiesfrommurinetransgenicplasmacells
AT frankgrosveld expressioncloningandproductionofhumanheavychainonlyantibodiesfrommurinetransgenicplasmacells
_version_ 1725477365543337984